HIF1α identified as key regulator that induces cancer-killing ability of hypoxic T cells, playing a role in ICB resistance.

The theory is solid, but creating such a bespoke vaccine quickly enough to be of use is a different matter. “Not many years ...

Women with heart disease appear to have a greater risk of aggressive breast cancer, according to a new study published Jan. 2 ...

Programmed cell death protein 1,” or PD-1, has been considered a key target in cancer therapies since its discovery in the ...

Veliparib plus temozolomide did not significantly extend overall survival in patients with newly diagnosed, ...

Long focused on antioxidants, researchers are now exploring a new route to combat prostate cancer: pro-oxidants.

UC San Diego researchers reveal key differences in PD-1 checkpoint receptors between rodents and humans. Rodent PD-1 is ...

Tumor Suppressor Protein Par-4 Triggers Unique Cell Death Pathway in Cancerous Cells July 23, 2024 — A team of researchers has discovered that the tumor suppressor protein Prostate apoptosis ...

After a double mastectomy, followed by chemotherapy, Hannah was confident that she'd beaten cancer. Even when cancer was ...

23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state ... of Colorectal Cancer Death, as Effective as Screening ...